Nataliya Berezina
Nataliya Berezina has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Mikhail A Cherkashin
Diagnostic and Treatment Center of the Sergey Berezin International Institute of Biological Systems
7 shared publications - A. A. Nikolaev
ООО «Лечебно-диагностический центр Международного института биологических систем имени Сергея Березина
4 shared publications - Konstantin F. Boyko
Diagnostic and Treatment Center of International Institution for Biological Systems named after Sergey Berezin
3 shared publications - Daria I. Kuplevatskaya
Медицинский институт Санкт-Петербургского государственного университета
2 shared publications - N. I. Martynova
Diagnostic and Treatment Center of International Institution for Biological Systems named after Sergey Berezin
2 shared publications - Sergei V. Aleksandrov
Medical Institute named after Berezin Sergey (MIBS), Saint Petersburg, Russia
2 shared publications
Latest Publications
- Open Access
- 23 December 2025
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 8 (4) , 60-71
A New Perspective on the Role of MRI in Refining PI-RADS 3 and PI-RADS 4 Categories
Introduction : Prostate cancer (PCa) remains one of the leading causes of cancer-related mortality. Traditional diagnostic methods, including PSA testing and transrectal ultrasound (TRUS), have limitations in detecting early-stage PCa. MRI plays a key role in diagnosis, particularly in identifying clinically significant tumors. However, the PI-RADS v2.1 system has limitations in the quantitative assessment of pathological changes. Purpose : To develop and evaluate quantitative MRI criteria for the differential diagnosis of PI-RADS 3 and PI-RADS 4 lesions, and to identify statistically significant predictors of cancer presence in lesions. Materials and Methods : A retrospective analysis was conducted on 105 patients (aged 49–78 years, median age 65) with suspected PCa from 2019 to 2024. Patients were grouped based on clinical history: negative biopsy (34 %), elevated PSA and negative MRI dynamics (33 %), and rising PSA without ultrasound changes (32 %). Prostate MRI was performed using 1.5 T and 3 T scanners (bi-or multiparametric), with assessment according to PI-RADS v2.1. PI-RADS 4 lesions were identiĮed in 73.3 % of cases, and PI-RADS 3 lesions in 26.7 %. All patients underwent stereotactic MRI-targeted biopsy with sampling from target lesions and systematic biopsy. Statistical analysis included frequency tables, chi-square and Fisher͛ s tests, t-test, Mann–Whitney test, and ROC analysis. Results : PCa was conĮrmed in 78 % of cases (predominantly Gleason 7, ISUP grade 2 adenocarcinomas). PI-RADS 3–4 lesions were most often located in the peripheral zones (73.3 %, posterior regions). New quantitative parameters were introduced: the signal intensity ratio on high b-value DWI (b 1 /b 2 ) and on ADC maps (ADC 2 /ADC 1 ). For all lesions, a b1/b2 threshold х1.56 showed sensitivity of 81.7 % and speciĮcity of 91.3 %; ADC 2 /ADC 1 >2.65 showed 52.4 % sensitivity and 82.6 % speciĮcity. For PI-RADS 4 lesions, thresholds of b1/b2 >1.57 (87.1 % sensitivity, 85.7 % speciĮcity) and ADC2/ADC1 >2.2 (81.4 % and 85.7 %, respectively) were significant predictors of cancer. For PI-RADS 3 lesions, these ratios were not significant. Dynamic contrast enhancement (performed in 34.2 % of cases) helped to reĮne lesion localization but did not influence the biopsy decision; type 3 curves correlated with cancer in PI-RADS 4 lesions (95 %). Discussion : The introduction of quantitative criteria (b 1 /b 2 and ADC 2 /ADC 1 ) allows for a more objective assessment of PI-RADS 4 lesions, reducing the dependence on radiologist experience. These parameters are signiĮcant predictors of clinically significant PCa, particularly in PI-RADS 4. Further research is needed to identify reliable quantitative markers for PI-RADS 3 lesions. Biparametric MRI (without contrast) was suĸcient for biopsy decision-making in most cases (65.7 %), making the method more accessible and safer. Quantitative analysis may assist in selecting between bi- and multiparametric MRI protocols. Conclusion : MRI with quantitative assessment of b 1 /b 2 and ADC 2 /ADC 1 improves the detection of clinically signiĮcant PCa, especially for PI-RADS 4 lesions. The b 1 /b 2 and ADC 2 /ADC 1 ratios are reliable cancer predictors for PI-RADS 4 and reduce diagnostic subjectivity. Using the proposed quantitative thresholds can support more informed decision-making regarding the need for biopsy in patients with equivocal MRI findings (PI-RADS 3 and 4).
- 23 December 2025
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 8 (4) , 60-71
Open AccessA New Perspective on the Role of MRI in Refining PI-RADS 3 and PI-RADS 4 Categories
Introduction : Prostate cancer (PCa) remains one of the leading causes of cancer-related mortality. Traditional diagnostic methods, including PSA testing and transrectal ultrasound (TRUS), have limitations in detecting early-stage PCa. MRI plays a key role in diagnosis, particularly in identifying clinically significant tumors. However, the PI-RADS v2.1 system has limitations in the quantitative assessment of pathological changes. Purpose : To develop and evaluate quantitative MRI criteria for the differential diagnosis of PI-RADS 3 and PI-RADS 4 lesions, and to identify statistically significant predictors of cancer presence in lesions. Materials and Methods : A retrospective analysis was conducted on 105 patients (aged 49–78 years, median age 65) with suspected PCa from 2019 to 2024. Patients were grouped based on clinical history: negative biopsy (34 %), elevated PSA and negative MRI dynamics (33 %), and rising PSA without ultrasound changes (32 %). Prostate MRI was performed using 1.5 T and 3 T scanners (bi-or multiparametric), with assessment according to PI-RADS v2.1. PI-RADS 4 lesions were identiĮed in 73.3 % of cases, and PI-RADS 3 lesions in 26.7 %. All patients underwent stereotactic MRI-targeted biopsy with sampling from target lesions and systematic biopsy. Statistical analysis included frequency tables, chi-square and Fisher͛ s tests, t-test, Mann–Whitney test, and ROC analysis. Results : PCa was conĮrmed in 78 % of cases (predominantly Gleason 7, ISUP grade 2 adenocarcinomas). PI-RADS 3–4 lesions were most often located in the peripheral zones (73.3 %, posterior regions). New quantitative parameters were introduced: the signal intensity ratio on high b-value DWI (b 1 /b 2 ) and on ADC maps (ADC 2 /ADC 1 ). For all lesions, a b1/b2 threshold х1.56 showed sensitivity of 81.7 % and speciĮcity of 91.3 %; ADC 2 /ADC 1 >2.65 showed 52.4 % sensitivity and 82.6 % speciĮcity. For PI-RADS 4 lesions, thresholds of b1/b2 >1.57 (87.1 % sensitivity, 85.7 % speciĮcity) and ADC2/ADC1 >2.2 (81.4 % and 85.7 %, respectively) were significant predictors of cancer. For PI-RADS 3 lesions, these ratios were not significant. Dynamic contrast enhancement (performed in 34.2 % of cases) helped to reĮne lesion localization but did not influence the biopsy decision; type 3 curves correlated with cancer in PI-RADS 4 lesions (95 %). Discussion : The introduction of quantitative criteria (b 1 /b 2 and ADC 2 /ADC 1 ) allows for a more objective assessment of PI-RADS 4 lesions, reducing the dependence on radiologist experience. These parameters are signiĮcant predictors of clinically significant PCa, particularly in PI-RADS 4. Further research is needed to identify reliable quantitative markers for PI-RADS 3 lesions. Biparametric MRI (without contrast) was suĸcient for biopsy decision-making in most cases (65.7 %), making the method more accessible and safer. Quantitative analysis may assist in selecting between bi- and multiparametric MRI protocols. Conclusion : MRI with quantitative assessment of b 1 /b 2 and ADC 2 /ADC 1 improves the detection of clinically signiĮcant PCa, especially for PI-RADS 4 lesions. The b 1 /b 2 and ADC 2 /ADC 1 ratios are reliable cancer predictors for PI-RADS 4 and reduce diagnostic subjectivity. Using the proposed quantitative thresholds can support more informed decision-making regarding the need for biopsy in patients with equivocal MRI findings (PI-RADS 3 and 4).
- 29 December 2022
- Published by ECO-Vector LLC in Russian Journal of Pediatric Surgery
- Vol. 26 (6) , 334-342
Venous thromboembolitic complications in children and adults with permanent venous access (literature review)
Introduction. Over the past decades, permanent venous access devices, in particular port systems and peripherally implanted central catheters, has been increasingly introduced in adult and pediatric oncology. As far as central catheters and permanent access devices are foreign bodies in basic veins, quite naturally that they are one more risk factor for thrombosis.Material and methods. The authors searched literature data ( in Russian and English) for the period up to May 3, 2022 using public databases (Embase, Medline/PubMed, Researchgate, medrxiv.org, RSCI/eLibrary). The following keywords were used for the search: “port-system”, “peripherally implanted central catheter”, “totally implanted vascular access device”, “venous thromboembolism”, “VTE”, “venous thromboembolic complications”, “VTEC”, “catheter dysfunction”, “device malfunction”. Available preprints, articles with “in press” or “online first” status, and clinical cases were also included in the analysis.Conclusion. This review discusses prevention, diagnostics and treatment of venous thromboembolic complications in cancer patients using similar implantable devices. In patients with catheter-associated thromboses, of practical interest are various diagnostic and curative algorithms, recommendations on the choice of vascular access, medicamentous therapy as well as variants of surgical intervention.
- 29 December 2022
- Published by ECO-Vector LLC in Russian Journal of Pediatric Surgery
- Vol. 26 (6) , 334-342
Venous thromboembolitic complications in children and adults with permanent venous access (literature review)
Introduction. Over the past decades, permanent venous access devices, in particular port systems and peripherally implanted central catheters, has been increasingly introduced in adult and pediatric oncology. As far as central catheters and permanent access devices are foreign bodies in basic veins, quite naturally that they are one more risk factor for thrombosis.Material and methods. The authors searched literature data ( in Russian and English) for the period up to May 3, 2022 using public databases (Embase, Medline/PubMed, Researchgate, medrxiv.org, RSCI/eLibrary). The following keywords were used for the search: “port-system”, “peripherally implanted central catheter”, “totally implanted vascular access device”, “venous thromboembolism”, “VTE”, “venous thromboembolic complications”, “VTEC”, “catheter dysfunction”, “device malfunction”. Available preprints, articles with “in press” or “online first” status, and clinical cases were also included in the analysis.Conclusion. This review discusses prevention, diagnostics and treatment of venous thromboembolic complications in cancer patients using similar implantable devices. In patients with catheter-associated thromboses, of practical interest are various diagnostic and curative algorithms, recommendations on the choice of vascular access, medicamentous therapy as well as variants of surgical intervention.
- Open Access
- 9 November 2022
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 9 (3) , 93-98-98
Non-surgical remove of hard-to-remove peripherally inserted central venous catheter: case report
A peripherally inserted central catheter (PICC) line allows permanent vascular access and is widely used in pediatric oncology. In patients, who fully completed antitumor treatment, the PICC line should be removed. In some cases, however, the procedure may be complicated and such a catheter is then called a ‘hard-to-remove’ or a ‘non-removable’. This article describes a clinical case of successful non-surgical removal of a PICC line with a developed fibrin sheath.
- 9 November 2022
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 9 (3) , 93-98-98
Open AccessNon-surgical remove of hard-to-remove peripherally inserted central venous catheter: case report
A peripherally inserted central catheter (PICC) line allows permanent vascular access and is widely used in pediatric oncology. In patients, who fully completed antitumor treatment, the PICC line should be removed. In some cases, however, the procedure may be complicated and such a catheter is then called a ‘hard-to-remove’ or a ‘non-removable’. This article describes a clinical case of successful non-surgical removal of a PICC line with a developed fibrin sheath.
- Open Access
- 13 September 2022
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (3S) , 5065
Experience in implementing a program for basic life support and available automated defibrillation in a cancer center
Unified approaches to ensuring the chain of survival can improve the patient’s prognosis both in out-of-hospital and in-hospital cardiac arrest.Aim. To discuss practical issues of introducing a program for the availability of automated external defibrillation in a cancer center.Material and methods. For four years, our healthcare facility has been implementing a training program for basic and advanced life support according to the European Resuscitation Council standards, combined with the creation and development of an infrastructure for the availability of automatic defibrillation. A roadmap and infrastructure were developed for the project implementation.Results. In 2018-2022, 229 employees (114 doctors, 85 nurses and 30 nonmedical workers) were trained under the basic life support program. Fifteen defibrillators were placed in various units. During the specified period, first aid in case of sudden cardiac arrest using an automated external defibrillator before the resuscitation team arrival was independently provided by doctors and nurses of departments three times. To implement training in the continuous education system, the curriculum has passed the examination and accreditation in the edu. rosminzdrav system.Conclusion. The development and implementation of such initiatives requires significant organizational and methodological work, including continuous education system. However, in our opinion, this is an extremely useful tool for improving the safety and quality of medical care.
- 13 September 2022
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (3S) , 5065
Open AccessExperience in implementing a program for basic life support and available automated defibrillation in a cancer center
Unified approaches to ensuring the chain of survival can improve the patient’s prognosis both in out-of-hospital and in-hospital cardiac arrest.Aim. To discuss practical issues of introducing a program for the availability of automated external defibrillation in a cancer center.Material and methods. For four years, our healthcare facility has been implementing a training program for basic and advanced life support according to the European Resuscitation Council standards, combined with the creation and development of an infrastructure for the availability of automatic defibrillation. A roadmap and infrastructure were developed for the project implementation.Results. In 2018-2022, 229 employees (114 doctors, 85 nurses and 30 nonmedical workers) were trained under the basic life support program. Fifteen defibrillators were placed in various units. During the specified period, first aid in case of sudden cardiac arrest using an automated external defibrillator before the resuscitation team arrival was independently provided by doctors and nurses of departments three times. To implement training in the continuous education system, the curriculum has passed the examination and accreditation in the edu. rosminzdrav system.Conclusion. The development and implementation of such initiatives requires significant organizational and methodological work, including continuous education system. However, in our opinion, this is an extremely useful tool for improving the safety and quality of medical care.
- Open Access
- 30 June 2022
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (2) , 16-24-24
The role of «point of care ultrasound» in medical triage of COVID-19 patients: a systematic review
INTRODUCTION: In the conditions of primary triage of patients with the new coronavirus infection, various medical imaging methods, including «point of care ultrasound», have become key.OBJECTIVE: The aim of this paper is to review data published during the pandemic on the assessment of the role of various ultrasound diagnostic methods in medical triage of patients with COVID-19.MATERIALS AND METHODS: The authors performed a systematic literature search in Russian and English for the period up to March 10, 2022 using various databases and repositories (Embase, Medline/PubMed, Researchgate, medrxiv.org, RSCI/elibrary). The search was carried out on the keywords «COVID-19», «coronavirus», «коронавирус», «SARS-CoV-2», «2019nCOV», «lung ultrasound», «POCUS», «point of care ultrasound», «прикроватный ультразвук», «ультразвуковое сканирование легких», «triage», «сортировка».RESULTS: The final analysis included 42 publications on different aspects of the use of point of care ultrasound during the pandemic. Of considerable interest are the technical features of the research, classifications and triage algorithms used in different countries.CONCLUSION: The widespread introduction of «point of care ultrasound» technology in the prehospital, emergency department and intensive care units greatly facilitates clinical decision making, including in the initial assessment of the severity of the condition of patients with pneumonia caused by SARS-CoV-2.
- 30 June 2022
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (2) , 16-24-24
Open AccessThe role of «point of care ultrasound» in medical triage of COVID-19 patients: a systematic review
INTRODUCTION: In the conditions of primary triage of patients with the new coronavirus infection, various medical imaging methods, including «point of care ultrasound», have become key.OBJECTIVE: The aim of this paper is to review data published during the pandemic on the assessment of the role of various ultrasound diagnostic methods in medical triage of patients with COVID-19.MATERIALS AND METHODS: The authors performed a systematic literature search in Russian and English for the period up to March 10, 2022 using various databases and repositories (Embase, Medline/PubMed, Researchgate, medrxiv.org, RSCI/elibrary). The search was carried out on the keywords «COVID-19», «coronavirus», «коронавирус», «SARS-CoV-2», «2019nCOV», «lung ultrasound», «POCUS», «point of care ultrasound», «прикроватный ультразвук», «ультразвуковое сканирование легких», «triage», «сортировка».RESULTS: The final analysis included 42 publications on different aspects of the use of point of care ultrasound during the pandemic. Of considerable interest are the technical features of the research, classifications and triage algorithms used in different countries.CONCLUSION: The widespread introduction of «point of care ultrasound» technology in the prehospital, emergency department and intensive care units greatly facilitates clinical decision making, including in the initial assessment of the severity of the condition of patients with pneumonia caused by SARS-CoV-2.
- Open Access
- 30 April 2022
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 9 (1) , 60-66-66
The use of proton radiation therapy in a patient with melanotic neuroectodermal tumor of infants of the anterior fontanel: description of a clinical case
Melanotic neuroectodermal tumor (MNET) of infants is a rare benign neoplasm detected mainly in children of the first year of life. Standard therapy consists of radical surgical removal of the tumor. Currently, the treatment of patients with recurrent and unresectable forms of the disease is relevant. The number of publications using polychemotherapy and radiation therapy is extremely limited. This article describes a clinical case of the occurrence of MNET in the anterior fontanel with a recurrent course. Proton radiation therapy was chosen as an alternative treatment method.
- 30 April 2022
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 9 (1) , 60-66-66
Open AccessThe use of proton radiation therapy in a patient with melanotic neuroectodermal tumor of infants of the anterior fontanel: description of a clinical case
Melanotic neuroectodermal tumor (MNET) of infants is a rare benign neoplasm detected mainly in children of the first year of life. Standard therapy consists of radical surgical removal of the tumor. Currently, the treatment of patients with recurrent and unresectable forms of the disease is relevant. The number of publications using polychemotherapy and radiation therapy is extremely limited. This article describes a clinical case of the occurrence of MNET in the anterior fontanel with a recurrent course. Proton radiation therapy was chosen as an alternative treatment method.
- 1 January 2022
- Published by Media Sphere Publishing Group in Journal of Venous Disorders
- Vol. 16 (4)
Stent grafting during external beam proton and photon therapy in patients with malignant iliac vein invasion. A case series
В случаях проведения дистанционной лучевой терапии у пациентов с опухолевой инвазией в магистральные вены существует риск распада опухолевого тромба и массивного кровотечения, которое нередко может стать жизнеугрожающим. ЦЕЛЬ ИССЛЕДОВАНИЯ Критическое обсуждение результатов серии клинических наблюдений. МАТЕРИАЛ И МЕТОДЫ Обследованы 2 пациента (мужчина и женщина) с опухолевыми инвазиями магистральных вен (хондросаркома и нейроэндокринная опухоль малого таза), которые обратились в центр по поводу проведения химиолучевого лечения в 2018—2019 гг. У пациента имела место тяжелая экстравазальная компрессия наружной и общей подвздошных вен и нельзя было исключить инвазию, у пациентки — прорастание через сосудистую стенку и опухолевый тромб наружной и общей подвздошной вены. Во всех случаях риск распада опухолевого тромба в зоне инвазии сосудистой стенки был оценен как крайне высокий, что потребовало применения различных эндоваскулярных технологий с целью его снижения. РЕЗУЛЬТАТЫ В обоих случаях была выполнена имплантация стент-графтов. Больные без осложнений перенесли специальное противоопухолевое лечение в объеме химиолучевой терапии (в одном случае VMAT на линейных ускорителях фотонов, в другом — протонную лучевую терапию). Удалось проследить дальнейшую судьбу пациентки в течение года, пациента — на протяжении 4 лет (наблюдение за ним продолжается). Технический успех имплантации оценивается как 100%. Клинически у обоих пациентов не развилось тяжелой венозной недостаточности с трофическими расстройствами, однако сохранялись отеки. С точки зрения эффективности противоопухолевого лечения в одном случае достигнута стабилизация, в другом — частичный регресс заболевания. ЗАКЛЮЧЕНИЕ Имплантация стент-графтов для профилактики массивных кровотечений у пациентов с опухолевыми инвазиями крупных сосудов технически выполнима, позволяет провести противоопухолевое лечение по радикальными программам, характеризуется хорошими отдаленными результатами с точки зрения качества жизни пациентов. Однако крайне ограниченный опыт и отсутствие масштабных клинических исследований в настоящее время являются ограничивающим фактором. В каждом конкретном случае необходимо очень тщательно оценивать риски кровотечения и индивидуализированно подходить к их устранению.
- 1 January 2022
- Published by Media Sphere Publishing Group in Journal of Venous Disorders
- Vol. 16 (4)
Stent grafting during external beam proton and photon therapy in patients with malignant iliac vein invasion. A case series
В случаях проведения дистанционной лучевой терапии у пациентов с опухолевой инвазией в магистральные вены существует риск распада опухолевого тромба и массивного кровотечения, которое нередко может стать жизнеугрожающим. ЦЕЛЬ ИССЛЕДОВАНИЯ Критическое обсуждение результатов серии клинических наблюдений. МАТЕРИАЛ И МЕТОДЫ Обследованы 2 пациента (мужчина и женщина) с опухолевыми инвазиями магистральных вен (хондросаркома и нейроэндокринная опухоль малого таза), которые обратились в центр по поводу проведения химиолучевого лечения в 2018—2019 гг. У пациента имела место тяжелая экстравазальная компрессия наружной и общей подвздошных вен и нельзя было исключить инвазию, у пациентки — прорастание через сосудистую стенку и опухолевый тромб наружной и общей подвздошной вены. Во всех случаях риск распада опухолевого тромба в зоне инвазии сосудистой стенки был оценен как крайне высокий, что потребовало применения различных эндоваскулярных технологий с целью его снижения. РЕЗУЛЬТАТЫ В обоих случаях была выполнена имплантация стент-графтов. Больные без осложнений перенесли специальное противоопухолевое лечение в объеме химиолучевой терапии (в одном случае VMAT на линейных ускорителях фотонов, в другом — протонную лучевую терапию). Удалось проследить дальнейшую судьбу пациентки в течение года, пациента — на протяжении 4 лет (наблюдение за ним продолжается). Технический успех имплантации оценивается как 100%. Клинически у обоих пациентов не развилось тяжелой венозной недостаточности с трофическими расстройствами, однако сохранялись отеки. С точки зрения эффективности противоопухолевого лечения в одном случае достигнута стабилизация, в другом — частичный регресс заболевания. ЗАКЛЮЧЕНИЕ Имплантация стент-графтов для профилактики массивных кровотечений у пациентов с опухолевыми инвазиями крупных сосудов технически выполнима, позволяет провести противоопухолевое лечение по радикальными программам, характеризуется хорошими отдаленными результатами с точки зрения качества жизни пациентов. Однако крайне ограниченный опыт и отсутствие масштабных клинических исследований в настоящее время являются ограничивающим фактором. В каждом конкретном случае необходимо очень тщательно оценивать риски кровотечения и индивидуализированно подходить к их устранению.
- Open Access
- 4 October 2017
- Published by BMJ in BMJ Case Reports
- Vol. 2017
CT and PET/CT fusion for lung cancer biopsy planning
- 4 October 2017
- Published by BMJ in BMJ Case Reports
- Vol. 2017
Open AccessCT and PET/CT fusion for lung cancer biopsy planning